cancer

Genetic Disorders Overview

  • Focus of upcoming presentations: Sickle cell anemia and Phenylketonuria (PKU).

  • Both conditions are classified as autosomal recessive disorders, meaning both copies of the gene in each cell have mutations.

Course Structure and Blackboard Organization

  • Transition from discussing genetic variants to cancer genetics due to upcoming presentations.

  • Classification of genetic variants: determining if a variant is benign, pathogenic, or somewhere in between.

  • Use of Blackboard for submission of PowerPoint presentations and access to resources.

  • Presentations should be uploaded by 01:30 on the day of the talk for proper organization.

  • Requirement for groups to email their selected research paper and specific figure for approval at least 1.5 to 2 weeks before the presentation.

    • Importance of research articles that include experiments and results, avoiding review papers for certain sections of the presentation.

    • Discussion board active for questions on the papers presented.

Cancer Genetics

  • Main focus: oncogenes and tumor suppressor genes as it relates to cancer genetics.

  • Analysis of recent cancer data from CDC focusing on incidence and mortality rates.

  • Observations about disparities in cancer statistics, lifestyle factors in heart disease and cancer prevalence.

    • Increased prevalence of chronic liver disease and cirrhosis in newer data.

  • Discussion on lifestyle choices impacting cancer rates; attention on trends over time.

    • Decrease in lung cancer incidences possibly due to smoking cessation efforts and education on smoking hazards.

Cancer Incidence and Survival

  • Comparative analysis of cancer incidence rates in males and females and associated factors,

    • Prostate cancer spikes due to increased testing (PSA exams), similar for breast cancer with screening advances.

    • Melanoma has increased incidence rates but lower mortality rates indicating better detection and treatment.

  • Lifetime cancer development risk noted at more than 1 in 3 individuals.

    • Increase in 5-year survival rates due to improved treatments, early detection, and lifestyle changes.

Genetics and Cancer

  • Differences between genetic mutations (causing cancer) and hereditary risks: genetic mutations can be sporadic or inherited.

  • Tumor behavior: benign tumors do not invade or spread, while malignant tumors do.

  • Characteristics of cancer cells, including loss of cell cycle regulation and altered apoptosis pathways.

Mechanisms of Oncogenesis

  • Key terms: oncogenes (positive regulators of cell division) and tumor suppressor genes (negative regulators).

    • Mutations in oncogenes tend to be dominant while mutations in tumor suppressor genes are typically recessive requiring two hits (mutations) for effect.

    • Examples: BRCA1 and BRCA2 as tumor suppressor genes.

Group Activity

  • Task involves researching specific genes related to cancer, their normal functions, and implications for cancer risk and treatment.

  • Students to provide sources and categorize genes based on whether they are oncogenes, tumor suppressor genes, or involved in genome stability/apoptosis.